Hall Laurie J Trustee Sage Therapeutics, Inc. Transaction History

Hall Laurie J Trustee

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 11, 2023	SELL	$32.2 - $43.61 $1,127 - $1,526	-35 Reduced 38.89%	55 $2,000
Q3 2022 Oct 11, 2022	SELL	$32.28 - $43.27 $1,291 - $1,730	-40 Reduced 30.77%	90 $4,000
Q3 2021 Oct 04, 2021	BUY	$40.26 - $57.37 $2,013 - $2,868	50 Added 62.5%	130 $6,000
Q3 2020 Oct 09, 2020	BUY	$41.13 - $62.45 $3,290 - $4,996	80 New	80 $5,000

220

52.7M

207K

191K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $730M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Hall Laurie J Trustee, based on Form 13F filings with the SEC.

Stay updated on Hall Laurie J Trustee with notifications on news.